A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients 

Slides:



Advertisements
Similar presentations
Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 
Advertisements

Lost in translation The Journal of Thoracic and Cardiovascular Surgery
Manuel J. Antunes, MD, PhD, DSc 
Inhaled nitric oxide reduces human lung allograft dysfunction
Lobar lung transplantation: One size fits all
I know what the studies say, but what should I do for my patient?
Mitral stenosis with pulmonary hypertension: We should operate early
One in every 14 patients with early-stage lung cancer is not being treated!  Benny Weksler, MD, MBA  The Journal of Thoracic and Cardiovascular Surgery 
It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible  Alessandro Brunelli,
Amiodarone after surgical ablation for atrial fibrillation: Is it really necessary? A prospective randomized controlled trial  Niv Ad, MD, Sari D. Holmes,
Lung cancer screening: No more excuses
Yesterday's heroic measure is now standard procedure: Extracorporeal membrane oxygenation as a bridge to lung transplant  Victor van Berkel, MD, PhD 
Ian Adatia, FRCP(C), Andrew M. Atz, MD, Richard A. Jonas, MD, David L
Ground glass opacity of the lung: The veil that needs lifting
Are preoperative B-type natriuretic peptide levels associated with outcome after pulmonary artery banding and the double switch operation in patients.
Juan A. Crestanello, MD, Richard C. Daly, MD 
Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 
Defining operative mortality: Impact on outcome reporting
Form ever follows function
The Journal of Thoracic and Cardiovascular Surgery
Application of a neuroscience research model to study neuroprotection in children with congenital heart disease  Nobuyuki Ishibashi, MD, Richard A. Jonas,
Marye J. Gleva, MD, Charles B. Huddleston, MD 
How should we treat air leaks?
Surgeons, valve repair in severely unbalanced atrioventricular septal defect, and the emperor's new clothes  David M. Overman, MD  The Journal of Thoracic.
Commentary: Pursuit of the green jacket: Mastery of the long and short games  Daniel P. Raymond, MD  The Journal of Thoracic and Cardiovascular Surgery 
The lord of the rings  Antonio Miceli, MD, PhD 
Acute left ventricular failure after bilateral lung transplantation for idiopathic pulmonary arterial hypertension  Tom Verbelen, MD, Sophie Van Cromphaut,
Aditya K. Kaza, MD  The Journal of Thoracic and Cardiovascular Surgery 
Juan N. Pulido, MD  The Journal of Thoracic and Cardiovascular Surgery 
Sildenafil augments the effect of inhaled nitric oxide for postoperative pulmonary hypertensive crises  Andrew M. Atz, MDa, Amy K. Lefler, PharmDb, David.
It's not “just a shunt” but sometimes it should be…
Nikolaos Skubas, MD, Hendrick B
Bartley P. Griffith, MD, FACS, FRCS 
A first start for lung transplantation?
A simplified technique for pulmonary artery aneurysm repair in a lung transplant recipient with right ventricular outflow tract obstruction  Giorgio Zanotti,
Niv Ad, MD, Sari D. Holmes, PhD, Paul S. Massimiano, MD, Anthony J
A randomized comparison of different ventilator strategies during thoracotomy for pulmonary resection  Andrew D. Maslow, MD, Todd S. Stafford, MD, Kristopher.
David L. Joyce, MD  The Journal of Thoracic and Cardiovascular Surgery 
Leora B. Balsam, MD, Abe DeAnda, MD 
Niv Ad, MD, Lawrence M. Wei, MD 
Shinya Murakami, MD. , Emile A. Bacha, MD
Frank C. Spencer, MD, FACS, pioneering cardiothoracic surgeon
A fate worse than death  Jennifer S. Lawton, MD 
Randomized controlled study of inhaled nitric oxide after operation for congenital heart disease  Ronald W Day, MD, John A Hawkins, MD, Edwin C McGough,
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
Use of two recipient lists for adults requiring heart transplantation
Shunt right or left? Decision 2016
Ralph S. Mosca, MD  The Journal of Thoracic and Cardiovascular Surgery 
The origins of open heart surgery at the University of Minnesota 1951 to 1956  Richard A. DeWall, MD  The Journal of Thoracic and Cardiovascular Surgery 
Jeffrey H. Shuhaiber, MD, Jeff Moore, MS, David B. Dyke, MD 
Tissue oxygenation index is a useful monitor of histologic and neurologic outcome after cardiopulmonary bypass in piglets  Ikuo Hagino, MD, Vesa Anttila,
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
The future of cardiac surgery training: A survival guide
Commentary: “Isn't cardiac surgery a team sport?”
After neoadjuvant chemoradiation therapy, predicted pulmonary function may be reduced by 10%  Benny Weksler, MD, MBA  The Journal of Thoracic and Cardiovascular.
“The more things change…”: The challenges ahead
Large clinical databases for the study of lung cancer: Making up for the failure of randomized trials  Chi-Fu Jeffrey Yang, MD, Matthew G. Hartwig, MD,
Rebound Pulmonary Hypertension After Inhalation of Nitric Oxide
Managing conflicts of interest
Commentary: Just say NO
More than vital: Who bears the burden?
Energized lung resections
Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery  Raja M. Flores, MD  The Journal.
American College of Cardiology/American Heart Association 2016 dual antiplatelet therapy (DAPT) focused update: Implications for surgeons  Richard J.
Preoperative PFTs: The answer is blowing in the wind
The evolution of cardiothoracic critical care
Journal changes and initiatives
Edward Y. Chan, MD, Michael J. Reardon, MD 
Cavoaortic shunt improves hemodynamics with preserved oxygen delivery in experimental right ventricular failure during left ventricular assist device.
Presentation transcript:

A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients  Tanveer A. Khan, MD, Gabriel Schnickel, MD, David Ross, MD, Sam Bastani, DO, Hillel Laks, MD, Fardad Esmailian, MD, Daniel Marelli, MD, Ramin Beygui, MD, Richard Shemin, MD, Larry Watson, BS, Irina Vartapetian, BS, Abbas Ardehali, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 138, Issue 6, Pages 1417-1424 (December 2009) DOI: 10.1016/j.jtcvs.2009.04.063 Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Time line for the experimental protocol and data collection. Patients were randomized to a pulmonary vasodilator, shown as Agent A, which was continued for 6 hours. Agent A was then stopped for 30 minutes for washout. Next, the crossover agent, shown as Agent B, was started and continued for 30 minutes. Therapy was then switched back to agent A, which was continued or weaned per the clinicians' decision. Time points (arrows) for collection of hemodynamic and oxygenation parameters. The Journal of Thoracic and Cardiovascular Surgery 2009 138, 1417-1424DOI: (10.1016/j.jtcvs.2009.04.063) Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Flow diagram depicting the outcome of all screened and enrolled patients. NO, Nitric oxide; PGI2, prostacyclin. The Journal of Thoracic and Cardiovascular Surgery 2009 138, 1417-1424DOI: (10.1016/j.jtcvs.2009.04.063) Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 NO and PGI2 similarly reduce PA pressures at the 6-hour crossover trial. NO and PGI2 showed significant reductions in systolic, diastolic, and mean PA pressures compared with crossover baseline (∗P < .01). NO, Nitric oxide; PA, pulmonary artery; PGI2, prostacyclin. The Journal of Thoracic and Cardiovascular Surgery 2009 138, 1417-1424DOI: (10.1016/j.jtcvs.2009.04.063) Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions

Figure 4 NO and PGI2 similarly improve hemodynamics at the 6-hour crossover trial. NO and PGI2 therapy decreased CVP and improved cardiac index and Svo2 when compared with crossover baseline values (∗P < .01). NO, Nitric oxide; PGI2, prostacyclin; Svo2, venous oxygen saturation. The Journal of Thoracic and Cardiovascular Surgery 2009 138, 1417-1424DOI: (10.1016/j.jtcvs.2009.04.063) Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions